Manufacturing Services Agreement by and between Tercica Medica, Inc. And Cambrex Bio Science Baltimore, Inc.Quality Agreement • September 22nd, 2003 • Tercica Inc • Pharmaceutical preparations • New York
FIRST AMENDMENT TO THE LICENSE AND COLLABORATION AGREEMENTLicense and Collaboration Agreement • September 22nd, 2003 • Tercica Inc • Pharmaceutical preparations
This FIRST AMENDMENT TO THE LICENCE AND COLLABORATION AGREEMENT (this “Amendment No. 1”) is made effective as of the 25th day of July, 2003 (the “Effective Date”) by and between Tercica Medica, Inc., a Delaware corporation having an office located at 651 Gateway Boulevard, Suite 950, South San Francisco, California 94080 (“TM”) and Genentech, Inc., a Delaware corporation having an office at 1 DNA Way, South San Francisco, California 94080 (“GNE”). TM and GNE are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
